Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma [Phase 1, Phase 2]
This is an update on a completed Phase 1/2 trial evaluating chemotherapy, SU5416, radiation therapy, and surgery in soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma [Phase 2]
A Phase 2 trial evaluating imatinib mesylate in patients with advanced soft tissue sarcoma or bone sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating a vaccine therapy for patients with recurrent soft tissue sarcoma. The spon…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma [Phase 3]
A Phase 3 trial of combination chemotherapy for previously untreated rhabdomyosarcoma (including adult and pediatric patients) has completed…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [Phase 2]
Phase 2 trial evaluating oxaliplatin in young patients with recurrent solid tumors that have not responded to prior treatment has completed.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of erlotinib and temozolomide in pediatric patients with recurrent or refractory solid tumors has c…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial of perifosine for advanced soft tissue sarcoma has completed enrollment; the update does not include trial results.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 trial of temsirolimus (CCI-779) in soft tissue sarcoma and gastrointestinal stromal tumor has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial of pomalidomide (CC-4047) in advanced soft tissue sarcoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: RAD001 in Advanced Sarcoma [Phase 2]
Phase 2 trial of RAD001 (everolimus) in advanced soft tissue sarcoma and bone sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall [Phase 1, Phase 2]
Results from a Phase 1/2 trial evaluating neoadjuvant conformal radiotherapy plus sorafenib in soft tissue sarcoma of the extremities and bo…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase II study of Everolimus in children and adolescents with refractory or relapsed rhabdomyosarcoma and other soft tissue sarcomas; the cu…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating the combination of doxorubicin hydrochloride and alvocidib in patients with metastatic or recurrent soft tissue sar…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating the combination of gemcitabine, docetaxel, and filgrastim in patients with recurrent or persistent leiomyosarcoma o…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure [Phase 2]
Phase 2 trial evaluating oral panobinostat (LBH589) for efficacy and safety in adults with advanced soft tissue sarcoma after prior treatmen…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans [Phase 2]
Phase 2 trial evaluating imatinib mesylate in patients with locally recurrent or metastatic dermatofibrosarcoma protuberans.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas [Phase 2]
A Phase 2 study of SU5416 in patients with advanced, metastatic, or recurrent soft tissue sarcomas, including gastrointestinal stromal tumor…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update showing Dolastatin 10 in patients with recurrent or metastatic soft tissue sarcoma has completed; ovarian cancer is lis…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial assessing isolated limb infusion of chemotherapy for patients with melanoma or soft tissue sarcoma of the arm or leg that cann…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma [Phase 1]
A Phase 1 safety study evaluating the combination of Yondelis (trabectedin) and doxorubicin in patients with soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) [Phase 2]
A phase 2 trial comparing trofosfamide to Adriamycin in elderly patients with soft tissue sarcoma; the current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial evaluating the interaction of docetaxel and lonafarnib in patients with advanced cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas [Phase 2]
Phase 2 trial S0505 evaluated sorafenib in patients with advanced soft tissue sarcoma; the study has completed and results were posted in 20…